[1]
“Increasing The Use Of Continuous Erythropoietin Receptor Activators To Correct Anemia In Maintenance Hemodialysis Patients.: Reprinted for our readers interest originally published PJKD 2018;2(4):9-11”., Pak J Kidney Dis, c. 3, sy 2, Şub. 2021, doi: 10.53778/pjkd32127.